Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Le Bras

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 23, 2006
Falciparum malaria acquired by a French tourist in a resort area of the Dominican RepublicEric D' Ortenzio, Daniel Bonnet, Catherine Leport, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentrationHalima Kaddouri, Serge Nakache, Sandrine Houzé, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2014
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsGilles Cottrell, Lise Musset, Véronique Hubert, et al.
Archives of Internal Medicine|July 19, 2002
Predictive factors of malaria in travelers to areas where malaria is endemicEnrique Casalino, Jacques Le Bras, Florence Chaussin, et al.
Microbes and Infection|September 12, 2006
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutationsLise Musset, Olivier Bouchaud, Sophie Matheron, et al.
Journal of Clinical Microbiology|May 6, 2011
Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic testSandrine Houzé, Véronique Hubert, Gaëlle Le Pessec, et al.
Malaria Journal|September 29, 2011
Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic settingSandrine Houzé, Véronique Hubert, Dorit Pessler Cohen, et al.
Computers in Biology and Medicine|December 3, 2014
Benefits of a new Metropolis-Hasting based algorithm, in non-linear regression for estimation of ex vivo antimalarial sensitivity in patients infected with two strainsRebecca Bauer, France Mentré, Halima Kaddouri, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2005
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellersLise Musset, Bruno Pradines, Daniel Parzy, et al.
The American Journal of Tropical Medicine and Hygiene|September 24, 2004
Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro testsAgnes Aubouy, Justice Mayombo, Annick Keundjian, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 23, 2006
Falciparum malaria acquired by a French tourist in a resort area of the Dominican RepublicEric D' Ortenzio, Daniel Bonnet, Catherine Leport, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentrationHalima Kaddouri, Serge Nakache, Sandrine Houzé, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2014
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsGilles Cottrell, Lise Musset, Véronique Hubert, et al.
Archives of Internal Medicine|July 19, 2002
Predictive factors of malaria in travelers to areas where malaria is endemicEnrique Casalino, Jacques Le Bras, Florence Chaussin, et al.
Microbes and Infection|September 12, 2006
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutationsLise Musset, Olivier Bouchaud, Sophie Matheron, et al.
Journal of Clinical Microbiology|May 6, 2011
Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic testSandrine Houzé, Véronique Hubert, Gaëlle Le Pessec, et al.
Malaria Journal|September 29, 2011
Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic settingSandrine Houzé, Véronique Hubert, Dorit Pessler Cohen, et al.
Computers in Biology and Medicine|December 3, 2014
Benefits of a new Metropolis-Hasting based algorithm, in non-linear regression for estimation of ex vivo antimalarial sensitivity in patients infected with two strainsRebecca Bauer, France Mentré, Halima Kaddouri, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2005
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellersLise Musset, Bruno Pradines, Daniel Parzy, et al.
The American Journal of Tropical Medicine and Hygiene|September 24, 2004
Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro testsAgnes Aubouy, Justice Mayombo, Annick Keundjian, et al.
Pageof 7